glp 1 receptor drugs Comparing Ozempic, Wegovy and Other GLP-1 Is GLP-1 Safe for Weight

These agents mimic the biological action of the native incretin hormone GLP-1 but are structurally modified to resist degradation by the enzyme dipeptidyl peptidase 4 (DPP-4), thereby extending their half-life and duration of action (Zheng et al., 2024

95% CI, 0.10-0.34

By subscribing, you accept our Terms & Privacy Policy.

Effect of tirzepatide on blood pressure and lipids: a meta-analysis of randomized controlled trials

10 Adverse events were predominantly mild to moderate gastrointestinal symptoms, including nausea, vomiting, and decreased appetite, with no significant increases in hypoglycemia or cardiovascular events reported